menu search

Verona's ensifentrine: a promising novel treatment for copd patients

Verona Pharma's ensifentrine is a first-in-class, inhaled, dual inhibitor of the enzymes PDE3 and PDE4, target...

March 27, 2023, 2:31 am

Genelux: recent ipo with phase 3 stage oncolytic virus cancer therapy

GNLX IPO-ed recently, but the company has been around for two decades. The company develops an oncolytic virus...

March 26, 2023, 10:50 pm

Ideaya biosciences has a strong pipeline and looks investible

IDEAYA Biosciences, Inc.'s platform is synthetic lethality targeting cancer. The company has produced s...

March 24, 2023, 4:24 pm

Rocket lab targets $50 million launch price for neutron rocket to challenge spacex's falcon 9

Rocket Lab is targeting a $50 million launch price for its coming reusable launch vehicle called Neutro...

March 24, 2023, 3:57 pm

Hindenburg targets block, erasing more than $6.5 billion in market cap

CNBC's MacKenzie Sigalos reports on the market reaction to Hindenburg's latest report, this time targeting ...

March 24, 2023, 7:19 am

Options traders targeting 3 moving stocks today

Stocks are rebounding as Wall Street continues to unpack yesterday's interest rate hike, with investors considering the Fed's policy for the rest of t...

March 23, 2023, 2:58 pm

Bombardier shares take off as jet maker ups 2025 targets

Bombardier (TSX:BBD.B) shares have taken flight after the Montreal, Canada-based business jet manufacturer announced it is...

March 23, 2023, 10:19 am

Rakuten group to test market with public offer of banking arm

Japanese e-commerce giant Rakuten Group Inc (OTC:RKUNF) will test the market with public offer on the Tokyo stock exchange of its banking arm next mon...

March 22, 2023, 10:22 am

Facebook political microtargeting at center of gdpr complaints in germany

In its latest piece of strategic litigation, the precision-punching European privacy rights campaign group noyb has used data donated by users of the ...

March 21, 2023, 2:00 am

Meta pivoting to focus on ai ‘that will help with the ad targeting': analyst

Edward Jones Senior Equity Analyst David Heger details Meta's latest round of layoffs, its position in the digital advertising market, and its refocus...

March 20, 2023, 5:28 pm

Mirati's krazati: a strong competitor in the kras g12c-mutated nsclc market

Mirati Therapeutics specializes in developing cancer treatments targeting genetic and immunological cau...

March 20, 2023, 3:43 am

Brookfield infrastructure: a resolute 4.8% yield in these trying times

Brookfield Infrastructure Partners is paying out a 4.8% yield from a portfolio of highly cash-generative essential infrastructure assets. Fiscal 2022 ...

March 16, 2023, 9:18 pm

Is it too late to buy ulta beauty stock?

Sales are holding up well and margins are increasing. Ulta Beauty is targeting another year of solid re...

March 16, 2023, 10:15 am

Japan gold kicks off drilling at barrick alliance mizobe project in southern kyushu

Japan Gold (TSX-V:JG) Corp has announced the start of drilling at the Barrick Alliance Mizobe Project in southern Kyushu, Japan, which is one of six p...

March 16, 2023, 9:57 am

Warren buffett loads up on occidental stock as energy stocks plummet

Warren Buffett is targeting Occidental Petroleum share prices no higher than $62. The post Warren Buffe...

March 16, 2023, 9:33 am

Dollar tree: margin concerns and fair valuation

Economic conditions have both helped and hindered Dollar tree, with sales increasing but volume declining. DLTR is inherently a defensive bet,...

March 16, 2023, 4:06 am

Facebook's behavioral ads lacked legal basis, dutch court rules

In the latest blow to Meta's consentless behavioral ad-targeting business in Europe, a Dutch court has found the social media giant's Irish subsidiary...

March 15, 2023, 12:22 pm

7 biotech stocks that could be the next big thing

While the concept of high-risk speculation seems particularly dangerous at this juncture, gamblers may nevertheless want to consider the merits of...

March 15, 2023, 11:44 am

Oric pharma: small pfizer deal, cash, and a set of very early stage assets

ORIC has a few early stage cancer targeting molecules. In December, Pfizer made a small $25mn deal with...

March 15, 2023, 12:47 am

Volkswagen: still targeting an affordable ev by 2025

Volkswagen still wants to bring an affordable electric vehicle - costing around 25,000 euros ($26,790.00) in today's prices - to market by 2025, the c...

March 14, 2023, 7:24 am


Search within

Pages Search Results: